Skip to content

Role of pharmacist in diabetes management at community pharmacy

Patient satisfaction with pharmacist-led interventions in diabetes management at a community pharmacy: a randomised controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN10671625
Enrollment
200
Registered
2017-05-16
Start date
2016-12-01
Completion date
Unknown
Last updated
2023-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 diabetes mellitus Nutritional, Metabolic, Endocrine Type 2 diabetes mellitus

Interventions

Simple random sampling was used for the participants. There are different intervention strategies for the control and the experimental group: 1. The control group received routine medications and diet

Sponsors

The Islamia University of Bahawalpur
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients with type 2 diabetes mellitus (T2DM) diagnosed by a registered medical practitioner 2. Minimum one year T2DM history 3. Age 18-70 years 4. On anti-diabetes therapy 5. Co-morbidity may or may not be present 6. Minimum two follow-up visits within one month period from the date of registration in trial 7. Both male and female

Exclusion criteria

Exclusion criteria: 1. Type 1 diabetes 2. Diabetes insipidus 3. Gestational diabetes and other forms of diabetes 4. Age 70 5. Not on anti-diabetic therapy 6. Less than two follow-up visits within one month period from the date of registration in trial

Design outcomes

Primary

MeasureTime frame
1. Glycemic control, measured using the strip method Accu check performa meter at baseline and after the completion of 1 month of intervention 2. Patient satisfaction about the services provided during trial, measured using the DDSM-Q after the completion of 1 month of intervention

Secondary

MeasureTime frame
1. Perception of self-management of diabetes, measured using the DDSM-Q 2. Disease state knowledge, measured using the DDSM-Q 3. Quality of life, measured using the EQ-5D-3L 4. Medication adherence, measured using the MMAS Measured at baseline and after completion of 1 month of intervention

Countries

Pakistan

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026